Share Price and Basic Stock Data
Last Updated: January 15, 2026, 2:45 am
| PEG Ratio | -3.28 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
GHCL Ltd operates in the chemicals sector, primarily focusing on inorganic products such as caustic soda and soda ash. The company’s stock price stood at ₹555, with a market capitalization of ₹5,100 Cr. Over the past fiscal year, GHCL reported sales of ₹4,551 Cr for FY 2023, a substantial increase from ₹3,052 Cr in FY 2022. This growth trajectory reflects the company’s ability to capitalize on rising demand, particularly in the soda ash segment, which is essential for industries like glass manufacturing and detergents. However, the company’s sales have shown volatility in recent quarters, declining from ₹1,381 Cr in September 2022 to ₹805 Cr by September 2023, indicating seasonal fluctuations or potential market challenges. The trailing twelve months (TTM) revenue stands at ₹3,077 Cr, suggesting a contraction compared to the previous fiscal year. This decline could be attributed to various operational challenges or shifts in market dynamics, necessitating a closer examination of future strategies.
Profitability and Efficiency Metrics
GHCL’s profitability metrics indicate a robust operational framework, with a reported operating profit margin (OPM) of 22% and a net profit margin of 19.60% for FY 2025. The company recorded a net profit of ₹624 Cr, a decrease from ₹1,142 Cr in FY 2023, reflecting the impact of reduced sales and possibly rising costs. The interest coverage ratio (ICR) stood at an impressive 59.78x, showcasing the firm’s ability to meet its interest obligations comfortably. However, the OPM has shown a declining trend from 33% in FY 2023 to 28% in FY 2025, highlighting potential pressure on margins. Efficiency ratios also reveal a cash conversion cycle (CCC) of 183 days, indicating areas for improvement in working capital management. Overall, while GHCL demonstrates strong profitability metrics, the recent decline in net profit and operating margins warrants attention for sustained financial health.
Balance Sheet Strength and Financial Ratios
GHCL’s balance sheet exhibits a solid structure, with total reserves reported at ₹3,540 Cr and borrowings significantly low at ₹97 Cr. The company’s debt-to-equity ratio is a mere 0.02, indicating a conservative leverage approach and financial stability. The return on equity (ROE) is reported at 18.6%, while return on capital employed (ROCE) stands at 24.2%, both of which are favorable compared to industry norms, indicating efficient utilization of capital. Moreover, the company enjoys a current ratio of 5.31, reflecting strong liquidity and the ability to cover short-term liabilities. However, the decline in total assets from ₹5,133 Cr in FY 2023 to ₹4,185 Cr in FY 2025 raises concerns regarding asset management and potential future growth. Overall, GHCL’s balance sheet appears robust, but a closer look at asset utilization is necessary to ensure ongoing operational efficiency.
Shareholding Pattern and Investor Confidence
GHCL’s shareholding structure reveals a diverse ownership landscape, with promoters holding 18.97% of the company, while foreign institutional investors (FIIs) account for 25.67% and domestic institutional investors (DIIs) hold 10.52%. The public holds a substantial 44.82%, indicating a broad base of retail investors. The number of shareholders has fluctuated, showing a decline from 1,12,859 in March 2024 to 96,988 in September 2025, which may reflect investor sentiment amidst recent performance challenges. The consistent presence of FIIs suggests a level of confidence in GHCL’s long-term potential despite short-term fluctuations. However, the decreasing public shareholding could indicate waning interest or concerns regarding future performance. Overall, while institutional confidence remains strong, the decline in retail participation may pose challenges for GHCL in maintaining shareholder engagement.
Outlook, Risks, and Final Insight
Looking ahead, GHCL faces a mixed outlook characterized by both opportunities and risks. The company has established a strong position in the caustic soda market, which could benefit from increased demand in various industrial applications. However, the recent sales decline and shrinking profit margins highlight significant risks that could impact future growth. Operational challenges, including potential cost pressures and market competition, remain critical factors to monitor. Additionally, the company’s ability to effectively manage its cash conversion cycle will be essential for maintaining liquidity and operational efficiency. If GHCL can enhance sales strategies and optimize operations, it may regain momentum. Conversely, continued volatility in sales and margins could lead to further financial strain, necessitating strategic adjustments to navigate the evolving market landscape. Overall, GHCL’s strengths in profitability and balance sheet resilience provide a solid foundation, but proactive measures will be needed to mitigate risks and leverage growth opportunities.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Caprolactam Chemicals Ltd | 32.8 Cr. | 71.2 | 71.2/37.5 | 3,277 | 11.6 | 0.00 % | 0.48 % | 13.7 % | 10.0 |
| Standard Industries Ltd | 95.7 Cr. | 14.9 | 28.4/14.8 | 20.4 | 0.00 % | 7.81 % | 10.5 % | 5.00 | |
| Gujarat Alkalies & Chemicals Ltd | 3,540 Cr. | 482 | 753/467 | 23,601 | 759 | 3.28 % | 0.34 % | 1.13 % | 10.0 |
| GHCL Ltd | 5,070 Cr. | 551 | 779/511 | 8.90 | 378 | 2.18 % | 24.2 % | 18.6 % | 10.0 |
| Tata Chemicals Ltd | 19,625 Cr. | 770 | 1,027/742 | 60.2 | 877 | 1.43 % | 3.96 % | 1.20 % | 10.0 |
| Industry Average | 7,211.75 Cr | 385.85 | 5,397.62 | 389.00 | 1.20% | 7.11% | 8.14% | 9.17 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,381 | 1,102 | 1,120 | 1,019 | 805 | 798 | 823 | 830 | 793 | 779 | 781 | 796 | 721 |
| Expenses | 947 | 735 | 771 | 719 | 592 | 648 | 639 | 614 | 582 | 549 | 563 | 599 | 564 |
| Operating Profit | 434 | 367 | 349 | 299 | 213 | 150 | 184 | 217 | 211 | 230 | 218 | 197 | 157 |
| OPM % | 31% | 33% | 31% | 29% | 26% | 19% | 22% | 26% | 27% | 30% | 28% | 25% | 22% |
| Other Income | 1 | 4 | -3 | 230 | 11 | 14 | 17 | 18 | 17 | 29 | 23 | 27 | 17 |
| Interest | 11 | 10 | 10 | 8 | 7 | 6 | 5 | 4 | 4 | 4 | 4 | 2 | 2 |
| Depreciation | 32 | 22 | 27 | 24 | 26 | 26 | 26 | 27 | 28 | 28 | 28 | 27 | 28 |
| Profit before tax | 392 | 339 | 309 | 497 | 191 | 133 | 170 | 203 | 196 | 227 | 209 | 195 | 145 |
| Tax % | 25% | 26% | 27% | 14% | 25% | 25% | 26% | 26% | 21% | 26% | 28% | 26% | 26% |
| Net Profit | 293 | 252 | 227 | 426 | 143 | 100 | 125 | 151 | 155 | 168 | 150 | 144 | 107 |
| EPS in Rs | 30.60 | 26.38 | 23.70 | 44.60 | 14.94 | 10.43 | 13.04 | 15.73 | 16.17 | 17.59 | 15.69 | 15.00 | 11.11 |
Last Updated: January 1, 2026, 4:16 pm
Below is a detailed analysis of the quarterly data for GHCL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 721.00 Cr.. The value appears to be declining and may need further review. It has decreased from 796.00 Cr. (Jun 2025) to 721.00 Cr., marking a decrease of 75.00 Cr..
- For Expenses, as of Sep 2025, the value is 564.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 599.00 Cr. (Jun 2025) to 564.00 Cr., marking a decrease of 35.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 157.00 Cr.. The value appears to be declining and may need further review. It has decreased from 197.00 Cr. (Jun 2025) to 157.00 Cr., marking a decrease of 40.00 Cr..
- For OPM %, as of Sep 2025, the value is 22.00%. The value appears to be declining and may need further review. It has decreased from 25.00% (Jun 2025) to 22.00%, marking a decrease of 3.00%.
- For Other Income, as of Sep 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Jun 2025) to 17.00 Cr., marking a decrease of 10.00 Cr..
- For Interest, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 28.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.00 Cr. (Jun 2025) to 28.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 145.00 Cr.. The value appears to be declining and may need further review. It has decreased from 195.00 Cr. (Jun 2025) to 145.00 Cr., marking a decrease of 50.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 26.00%.
- For Net Profit, as of Sep 2025, the value is 107.00 Cr.. The value appears to be declining and may need further review. It has decreased from 144.00 Cr. (Jun 2025) to 107.00 Cr., marking a decrease of 37.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 11.11. The value appears to be declining and may need further review. It has decreased from 15.00 (Jun 2025) to 11.11, marking a decrease of 3.89.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:20 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,201 | 2,356 | 2,531 | 2,784 | 2,919 | 3,341 | 3,305 | 2,491 | 3,052 | 4,551 | 3,447 | 3,183 | 3,077 |
| Expenses | 1,767 | 1,828 | 1,901 | 2,103 | 2,313 | 2,582 | 2,576 | 1,886 | 2,322 | 3,048 | 2,596 | 2,306 | 2,275 |
| Operating Profit | 434 | 528 | 629 | 681 | 607 | 759 | 729 | 605 | 730 | 1,503 | 851 | 877 | 803 |
| OPM % | 20% | 22% | 25% | 24% | 21% | 23% | 22% | 24% | 24% | 33% | 25% | 28% | 26% |
| Other Income | -26 | -15 | -3 | 37 | 38 | 16 | 16 | 18 | 211 | 119 | 270 | 88 | 96 |
| Interest | 183 | 171 | 165 | 137 | 127 | 127 | 120 | 74 | 51 | 39 | 27 | 17 | 12 |
| Depreciation | 82 | 85 | 82 | 86 | 110 | 117 | 131 | 111 | 87 | 94 | 102 | 112 | 111 |
| Profit before tax | 143 | 257 | 380 | 495 | 407 | 531 | 495 | 437 | 802 | 1,489 | 991 | 836 | 776 |
| Tax % | 24% | 29% | 32% | 23% | 13% | 34% | 20% | 25% | 19% | 23% | 20% | 25% | |
| Net Profit | 109 | 182 | 258 | 380 | 356 | 351 | 397 | 326 | 650 | 1,142 | 794 | 624 | 570 |
| EPS in Rs | 10.85 | 18.19 | 25.78 | 38.04 | 36.59 | 35.77 | 41.75 | 34.33 | 68.14 | 119.41 | 82.94 | 65.18 | 59.39 |
| Dividend Payout % | 18% | 12% | 0% | 13% | 14% | 14% | 7% | 16% | 22% | 15% | 14% | 18% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 66.97% | 41.76% | 47.29% | -6.32% | -1.40% | 13.11% | -17.88% | 99.39% | 75.69% | -30.47% | -21.41% |
| Change in YoY Net Profit Growth (%) | 0.00% | -25.21% | 5.53% | -53.60% | 4.91% | 14.51% | -30.99% | 117.27% | -23.69% | -106.17% | 9.06% |
GHCL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -1% |
| 3 Years: | 1% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 9% |
| 3 Years: | -3% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 30% |
| 3 Years: | -1% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 22% |
| 3 Years: | 23% |
| Last Year: | 19% |
Last Updated: September 5, 2025, 4:40 am
Balance Sheet
Last Updated: December 4, 2025, 1:17 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 100 | 100 | 100 | 99 | 97 | 98 | 95 | 95 | 95 | 96 | 96 | 96 | 96 |
| Reserves | 487 | 670 | 936 | 1,247 | 1,513 | 1,827 | 2,054 | 2,389 | 2,852 | 3,860 | 2,883 | 3,393 | 3,540 |
| Borrowings | 1,486 | 1,324 | 1,365 | 1,463 | 1,322 | 1,302 | 1,254 | 782 | 788 | 361 | 210 | 119 | 97 |
| Other Liabilities | 941 | 758 | 548 | 694 | 695 | 767 | 766 | 712 | 1,261 | 816 | 581 | 578 | 540 |
| Total Liabilities | 3,014 | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 4,185 | 4,272 |
| Fixed Assets | 1,869 | 1,934 | 2,049 | 2,410 | 2,502 | 2,591 | 2,664 | 2,675 | 2,474 | 1,731 | 1,842 | 1,844 | 1,842 |
| CWIP | 12 | 7 | 37 | 26 | 74 | 117 | 122 | 81 | 213 | 109 | 55 | 256 | 370 |
| Investments | 7 | 2 | 15 | 9 | 10 | 12 | 9 | 15 | 17 | 380 | 420 | 651 | 831 |
| Other Assets | 1,125 | 909 | 848 | 1,059 | 1,043 | 1,275 | 1,375 | 1,207 | 2,292 | 2,914 | 1,453 | 1,435 | 1,229 |
| Total Assets | 3,014 | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 4,185 | 4,272 |
Below is a detailed analysis of the balance sheet data for GHCL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 96.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 96.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,540.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,393.00 Cr. (Mar 2025) to 3,540.00 Cr., marking an increase of 147.00 Cr..
- For Borrowings, as of Sep 2025, the value is 97.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 119.00 Cr. (Mar 2025) to 97.00 Cr., marking a decrease of 22.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 540.00 Cr.. The value appears to be improving (decreasing). It has decreased from 578.00 Cr. (Mar 2025) to 540.00 Cr., marking a decrease of 38.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,272.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,185.00 Cr. (Mar 2025) to 4,272.00 Cr., marking an increase of 87.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,842.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,844.00 Cr. (Mar 2025) to 1,842.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 370.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2025) to 370.00 Cr., marking an increase of 114.00 Cr..
- For Investments, as of Sep 2025, the value is 831.00 Cr.. The value appears strong and on an upward trend. It has increased from 651.00 Cr. (Mar 2025) to 831.00 Cr., marking an increase of 180.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,229.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,435.00 Cr. (Mar 2025) to 1,229.00 Cr., marking a decrease of 206.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,272.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,185.00 Cr. (Mar 2025) to 4,272.00 Cr., marking an increase of 87.00 Cr..
Notably, the Reserves (3,540.00 Cr.) exceed the Borrowings (97.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 433.00 | 527.00 | 628.00 | 680.00 | 606.00 | 758.00 | 728.00 | -177.00 | -58.00 | -360.00 | 641.00 | 758.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63 | 38 | 26 | 36 | 29 | 32 | 30 | 33 | 27 | 18 | 19 | 24 |
| Inventory Days | 227 | 193 | 194 | 187 | 182 | 199 | 198 | 245 | 294 | 177 | 185 | 217 |
| Days Payable | 233 | 155 | 110 | 107 | 109 | 106 | 102 | 121 | 107 | 53 | 55 | 57 |
| Cash Conversion Cycle | 57 | 76 | 110 | 117 | 101 | 125 | 126 | 158 | 214 | 142 | 149 | 183 |
| Working Capital Days | -52 | -39 | -48 | -30 | -12 | 10 | 26 | 61 | 87 | 50 | 50 | 58 |
| ROCE % | 17% | 22% | 25% | 24% | 19% | 21% | 19% | 16% | 19% | 36% | 21% | 24% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| DSP Small Cap Fund | 2,600,000 | 0.88 | 149.55 | 3,115,010 | 2025-12-07 00:37:57 | -16.53% |
| Franklin India Small Cap Fund | 1,449,472 | 0.62 | 83.37 | N/A | N/A | N/A |
| DSP ELSS Tax Saver Fund | 1,447,019 | 0.47 | 83.23 | N/A | N/A | N/A |
| ICICI Prudential Smallcap Fund | 850,000 | 0.58 | 48.89 | N/A | N/A | N/A |
| UTI Large & Mid Cap Fund | 733,571 | 0.77 | 42.2 | 603,132 | 2025-12-14 01:33:34 | 21.63% |
| UTI Aggressive Hybrid Fund | 670,600 | 0.57 | 38.57 | 572,260 | 2025-12-14 01:33:34 | 17.18% |
| HDFC Dividend Yield Fund | 400,000 | 0.37 | 23.01 | N/A | N/A | N/A |
| UTI Retirement Fund | 206,972 | 0.25 | 11.91 | 191,742 | 2025-12-14 01:33:34 | 7.94% |
| Mahindra Manulife Flexi Cap Fund | 147,361 | 0.53 | 8.48 | 170,000 | 2025-12-14 01:33:34 | -13.32% |
| Mahindra Manulife ELSS Tax Saver Fund | 85,000 | 0.5 | 4.89 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 65.50 | 83.43 | 120.06 | 67.89 | 34.32 |
| Diluted EPS (Rs.) | 65.34 | 83.33 | 120.06 | 67.89 | 34.23 |
| Cash EPS (Rs.) | 76.83 | 93.61 | 129.28 | 80.36 | 48.37 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 364.37 | 311.17 | 413.83 | 324.73 | 261.47 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 364.37 | 311.17 | 413.83 | 324.73 | 261.47 |
| Revenue From Operations / Share (Rs.) | 332.48 | 360.06 | 475.51 | 397.68 | 305.24 |
| PBDIT / Share (Rs.) | 100.65 | 94.00 | 159.03 | 104.32 | 69.80 |
| PBIT / Share (Rs.) | 89.00 | 83.33 | 149.17 | 92.03 | 55.76 |
| PBT / Share (Rs.) | 87.32 | 103.58 | 153.05 | 85.34 | 46.16 |
| Net Profit / Share (Rs.) | 65.19 | 82.94 | 119.42 | 68.07 | 34.32 |
| NP After MI And SOA / Share (Rs.) | 65.19 | 82.94 | 119.42 | 68.07 | 34.32 |
| PBDIT Margin (%) | 30.27 | 26.10 | 33.44 | 26.23 | 22.86 |
| PBIT Margin (%) | 26.76 | 23.14 | 31.37 | 23.14 | 18.26 |
| PBT Margin (%) | 26.26 | 28.76 | 32.18 | 21.45 | 15.12 |
| Net Profit Margin (%) | 19.60 | 23.03 | 25.11 | 17.11 | 11.24 |
| NP After MI And SOA Margin (%) | 19.60 | 23.03 | 25.11 | 17.11 | 11.24 |
| Return on Networth / Equity (%) | 17.88 | 26.65 | 28.85 | 20.96 | 13.12 |
| Return on Capital Employeed (%) | 22.32 | 23.76 | 31.97 | 22.97 | 15.93 |
| Return On Assets (%) | 14.91 | 21.06 | 22.23 | 12.94 | 8.19 |
| Long Term Debt / Equity (X) | 0.01 | 0.03 | 0.06 | 0.13 | 0.22 |
| Total Debt / Equity (X) | 0.02 | 0.06 | 0.08 | 0.24 | 0.24 |
| Asset Turnover Ratio (%) | 0.80 | 0.77 | 0.89 | 0.84 | 0.69 |
| Current Ratio (X) | 5.31 | 4.30 | 4.69 | 1.82 | 1.71 |
| Quick Ratio (X) | 3.61 | 2.73 | 3.54 | 1.03 | 0.53 |
| Inventory Turnover Ratio (X) | 4.99 | 1.55 | 1.49 | 1.75 | 1.48 |
| Dividend Payout Ratio (NP) (%) | 18.32 | 20.96 | 12.49 | 8.08 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 15.54 | 18.57 | 11.54 | 6.84 | 0.00 |
| Earning Retention Ratio (%) | 81.68 | 79.04 | 87.51 | 91.92 | 0.00 |
| Cash Earning Retention Ratio (%) | 84.46 | 81.43 | 88.46 | 93.16 | 0.00 |
| Interest Coverage Ratio (X) | 59.78 | 35.33 | 39.31 | 15.59 | 7.27 |
| Interest Coverage Ratio (Post Tax) (X) | 39.72 | 23.56 | 27.90 | 10.41 | 4.58 |
| Enterprise Value (Cr.) | 5531.62 | 3948.48 | 5021.66 | 5717.82 | 2744.15 |
| EV / Net Operating Revenue (X) | 1.74 | 1.15 | 1.10 | 1.51 | 0.94 |
| EV / EBITDA (X) | 5.74 | 4.39 | 3.30 | 5.77 | 4.14 |
| MarketCap / Net Operating Revenue (X) | 1.85 | 1.23 | 1.06 | 1.38 | 0.75 |
| Retention Ratios (%) | 81.67 | 79.03 | 87.50 | 91.91 | 0.00 |
| Price / BV (X) | 1.69 | 1.42 | 1.22 | 1.69 | 0.88 |
| Price / Net Operating Revenue (X) | 1.85 | 1.23 | 1.06 | 1.38 | 0.75 |
| EarningsYield | 0.10 | 0.18 | 0.23 | 0.12 | 0.14 |
After reviewing the key financial ratios for GHCL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 65.50. This value is within the healthy range. It has decreased from 83.43 (Mar 24) to 65.50, marking a decrease of 17.93.
- For Diluted EPS (Rs.), as of Mar 25, the value is 65.34. This value is within the healthy range. It has decreased from 83.33 (Mar 24) to 65.34, marking a decrease of 17.99.
- For Cash EPS (Rs.), as of Mar 25, the value is 76.83. This value is within the healthy range. It has decreased from 93.61 (Mar 24) to 76.83, marking a decrease of 16.78.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 364.37. It has increased from 311.17 (Mar 24) to 364.37, marking an increase of 53.20.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 364.37. It has increased from 311.17 (Mar 24) to 364.37, marking an increase of 53.20.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 332.48. It has decreased from 360.06 (Mar 24) to 332.48, marking a decrease of 27.58.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 100.65. This value is within the healthy range. It has increased from 94.00 (Mar 24) to 100.65, marking an increase of 6.65.
- For PBIT / Share (Rs.), as of Mar 25, the value is 89.00. This value is within the healthy range. It has increased from 83.33 (Mar 24) to 89.00, marking an increase of 5.67.
- For PBT / Share (Rs.), as of Mar 25, the value is 87.32. This value is within the healthy range. It has decreased from 103.58 (Mar 24) to 87.32, marking a decrease of 16.26.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 65.19. This value is within the healthy range. It has decreased from 82.94 (Mar 24) to 65.19, marking a decrease of 17.75.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 65.19. This value is within the healthy range. It has decreased from 82.94 (Mar 24) to 65.19, marking a decrease of 17.75.
- For PBDIT Margin (%), as of Mar 25, the value is 30.27. This value is within the healthy range. It has increased from 26.10 (Mar 24) to 30.27, marking an increase of 4.17.
- For PBIT Margin (%), as of Mar 25, the value is 26.76. This value exceeds the healthy maximum of 20. It has increased from 23.14 (Mar 24) to 26.76, marking an increase of 3.62.
- For PBT Margin (%), as of Mar 25, the value is 26.26. This value is within the healthy range. It has decreased from 28.76 (Mar 24) to 26.26, marking a decrease of 2.50.
- For Net Profit Margin (%), as of Mar 25, the value is 19.60. This value exceeds the healthy maximum of 10. It has decreased from 23.03 (Mar 24) to 19.60, marking a decrease of 3.43.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.60. This value is within the healthy range. It has decreased from 23.03 (Mar 24) to 19.60, marking a decrease of 3.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.88. This value is within the healthy range. It has decreased from 26.65 (Mar 24) to 17.88, marking a decrease of 8.77.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.32. This value is within the healthy range. It has decreased from 23.76 (Mar 24) to 22.32, marking a decrease of 1.44.
- For Return On Assets (%), as of Mar 25, the value is 14.91. This value is within the healthy range. It has decreased from 21.06 (Mar 24) to 14.91, marking a decrease of 6.15.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.02, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.80. It has increased from 0.77 (Mar 24) to 0.80, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 5.31. This value exceeds the healthy maximum of 3. It has increased from 4.30 (Mar 24) to 5.31, marking an increase of 1.01.
- For Quick Ratio (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 2. It has increased from 2.73 (Mar 24) to 3.61, marking an increase of 0.88.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.99. This value is within the healthy range. It has increased from 1.55 (Mar 24) to 4.99, marking an increase of 3.44.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 18.32. This value is below the healthy minimum of 20. It has decreased from 20.96 (Mar 24) to 18.32, marking a decrease of 2.64.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.54. This value is below the healthy minimum of 20. It has decreased from 18.57 (Mar 24) to 15.54, marking a decrease of 3.03.
- For Earning Retention Ratio (%), as of Mar 25, the value is 81.68. This value exceeds the healthy maximum of 70. It has increased from 79.04 (Mar 24) to 81.68, marking an increase of 2.64.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.46. This value exceeds the healthy maximum of 70. It has increased from 81.43 (Mar 24) to 84.46, marking an increase of 3.03.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 59.78. This value is within the healthy range. It has increased from 35.33 (Mar 24) to 59.78, marking an increase of 24.45.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 39.72. This value is within the healthy range. It has increased from 23.56 (Mar 24) to 39.72, marking an increase of 16.16.
- For Enterprise Value (Cr.), as of Mar 25, the value is 5,531.62. It has increased from 3,948.48 (Mar 24) to 5,531.62, marking an increase of 1,583.14.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.74, marking an increase of 0.59.
- For EV / EBITDA (X), as of Mar 25, the value is 5.74. This value is within the healthy range. It has increased from 4.39 (Mar 24) to 5.74, marking an increase of 1.35.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.85, marking an increase of 0.62.
- For Retention Ratios (%), as of Mar 25, the value is 81.67. This value exceeds the healthy maximum of 70. It has increased from 79.03 (Mar 24) to 81.67, marking an increase of 2.64.
- For Price / BV (X), as of Mar 25, the value is 1.69. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.69, marking an increase of 0.27.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.85, marking an increase of 0.62.
- For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.18 (Mar 24) to 0.10, marking a decrease of 0.08.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in GHCL Ltd:
- Net Profit Margin: 19.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.32% (Industry Average ROCE: 7.11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.88% (Industry Average ROE: 8.14%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 39.72
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.61
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 8.9 (Industry average Stock P/E: 5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.6%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Caustic Soda/Soda Ash | GHCL House, Opp. Punjabi Hall, Ahmedabad Gujarat 380009 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anurag Dalmia | Non Executive Chairman |
| Mr. R S Jalan | Managing Director |
| Mr. Raman Chopra | Executive Director (Finance) & CFO |
| Mr. Neelabh Dalmia | Executive Director |
| Mrs. Vijaylaxmi Joshi | Independent Director |
| Dr. Manoj Vaish | Independent Director |
| Justice(Retd) Ravindra Singh | Independent Director |
| Mr. Arun Kumar Jain | Independent Director |
FAQ
What is the intrinsic value of GHCL Ltd?
GHCL Ltd's intrinsic value (as of 15 January 2026) is ₹511.51 which is 7.17% lower the current market price of ₹551.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹5,070 Cr. market cap, FY2025-2026 high/low of ₹779/511, reserves of ₹3,540 Cr, and liabilities of ₹4,272 Cr.
What is the Market Cap of GHCL Ltd?
The Market Cap of GHCL Ltd is 5,070 Cr..
What is the current Stock Price of GHCL Ltd as on 15 January 2026?
The current stock price of GHCL Ltd as on 15 January 2026 is ₹551.
What is the High / Low of GHCL Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of GHCL Ltd stocks is ₹779/511.
What is the Stock P/E of GHCL Ltd?
The Stock P/E of GHCL Ltd is 8.90.
What is the Book Value of GHCL Ltd?
The Book Value of GHCL Ltd is 378.
What is the Dividend Yield of GHCL Ltd?
The Dividend Yield of GHCL Ltd is 2.18 %.
What is the ROCE of GHCL Ltd?
The ROCE of GHCL Ltd is 24.2 %.
What is the ROE of GHCL Ltd?
The ROE of GHCL Ltd is 18.6 %.
What is the Face Value of GHCL Ltd?
The Face Value of GHCL Ltd is 10.0.